# 4D Molecular Therapeutics, Inc.: Form S-1/A, filed Dec 10, 2020

- Company: [4D Molecular Therapeutics, Inc.](/companies/fdmt.md) (CIK 1650648)
- Form: S-1/A
- Filed: 2020-12-10
- Accepted by EDGAR: Dec 10, 2020, 06:05 ET
- Period: not reported
- Accession: 0001193125-20-314317
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1650648/000119312520314317/d69563ds1a.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1650648/000119312520314317/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1650648/000119312520314317/d69563ds1a.htm

Filed Dec 10, 2020.
Source: SEC EDGAR, the filing index for accession 0001193125-20-314317. Last ingested by Listed: Nov 13, 2026, 16:07 ET. No prices; not investment advice.
